FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilevVARDIS HOLDING AG Class A
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
VVVV
vVARDIS HOLDING AG Class A Stock AnalysisComprehensive stock analysis for vVARDIS HOLDING AG Class A (VVVV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisVVVV
VVVV
vVARDIS HOLDING AG Class A
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
VVVV
  1. Home
  2. Stocks
  3. vVARDIS HOLDING AG Class A
VH

vVARDIS HOLDING AG Class A

🇺🇸VVVV•NYSE
VH

vVARDIS HOLDING AG Class A

🇺🇸VVVV•NYSE
Market cap
$597.06M
Sentiment

Your view on VVVV

Mkt Cap
$597.06M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About vVARDIS HOLDING AG Class A

Industry
Medical - Specialties
Sector
Healthcare
CEO
Goly Abivardi
Headquarters
Gubelstrasse 24, Zug, ZG, CH
Industry
Medical - Specialties
Sector
Healthcare
CEO
Goly Abivardi
Headquarters
Gubelstrasse 24, Zug, ZG, CH
Description

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States.

The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for vVARDIS HOLDING AG Class A from FRC's valuation model, read against the market price. VVVV last traded at $15.47; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for vVARDIS HOLDING AG Class A. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for vVARDIS HOLDING AG Class A. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold VVVV12 companies

More Medical - Specialties companies

Market cap

  • ACAISafeplus International Holdings LimitedOTC$477
  • ADLIAmerican Medical Technologies Inc.OTC$1,031
  • AIMVAI Maverick Intel, Inc.OTC$3M
  • ALCAlcon Inc.NYSE$36.2B
  • ANIKAnika Therapeutics, Inc.NASDAQ$182M
  • APYXApyx Medical CorporationNASDAQ$105M
  • ASFXAmerican Scientific Resources, IncorporatedOTC$7,001
  • AVTIAvitar, Inc.OTC$1,382
  • BEATHeartBeam, Inc.NASDAQ$22M
  • BEATWHeartBeam, Inc.NASDAQ$7M
  • BIELBioElectronics CorporationOTC$7M
  • BMGPBiomagnetics Diagnostics Corp.OTC$1,265
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold vVARDIS HOLDING AG Class A, and how their positions are changing. At a $597.1M market value, institutional positions materially move vVARDIS HOLDING AG Class A's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by vVARDIS HOLDING AG Class A executives and directors. Shares of vVARDIS HOLDING AG Class A have traded between $14.00 and $18.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A is a $597.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming vVARDIS HOLDING AG Class A. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for vVARDIS HOLDING AG Class A. Coverage tracks vVARDIS HOLDING AG Class A within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of vVARDIS HOLDING AG Class A.

VVVV Analysis
Weak
Past1
Growth1
Health1
Profit1
Value1

News

Latest Market News